<DOC>
	<DOCNO>NCT00103974</DOCNO>
	<brief_summary>This research study do evaluate safety BHT-3009 alone combine atorvastatin ( Lipitor ) patient multiple sclerosis ( MS ) .</brief_summary>
	<brief_title>Immunotherapy With BHT-3009 Alone Combined With Atorvastatin Patients With Multiple Sclerosis</brief_title>
	<detailed_description>This research study do evaluate safety BHT-3009 alone combine atorvastatin ( Lipitor ) patient multiple sclerosis ( MS ) . Patients MS think immune response attack certain protein brain , include myelin basic protein . ( Myelin basic protein protein make part outside layer nerve cell . ) BHT-3009 investigational immunotherapy product design alter immune response myelin basic protein make response less harmful . BHT-3009 contains DNA ( gene ) myelin basic protein . Three different dos BHT-3009 test determine difference safety effect immunity . This first clinical research study BHT-3009 . Laboratory study show BHT-3009 atorvastatin give together alters immune response myelin basic protein make response less harmful .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Definite diagnosis multiple sclerosis McDonald criterion . Patients relapse remit MS secondary progressive MS eligible . 15 gadolinium enhancing ( Gd+ ) lesion first Screening MRI relapse previous 2 year , disease worsen previous 2 year Clinically stable &gt; 1 month screen evaluation screening . Patients stable approved therapy eligible intolerable side effect medical reason discontinue approve therapy . Off interferon &gt; 1 month screen evaluation . Off immunosuppressive cytotoxic therapy ( e.g . mitoxantrone , cladrabine ) &gt; 12 month &gt; 6 month CD4 count &gt; 400 . EDSS â‰¥ 2.5 &lt; 7.0 . Female male , age &gt; 18 year . Able give inform consent . WBC platelets normal range , hemoglobin &gt; 10.0 g/dl . AST , ALT , bilirubin &lt; upper limit normal . Creatinine &lt; upper limit normal . CPK &lt; upper limit normal . Highdose corticosteroid ( e.g . &gt; 500 mg methylprednisolone equivalent ) within previous month . &gt; 5 Gd+ lesion first Screening MRI . Previous vaccine therapy , stem cell transplantation total lymphoid radiation . Glatiramer within previous 12 month . Treatment statin previous 6 month elevate cholesterol require treatment statin . Pregnant lactating woman . Unwilling use medically acceptable form birth control . History positive test HIV , hepatitis B hepatitis C. Clinically significant ECG abnormality . Medical condition social circumstance would opinion investigator prevent full participation trial evaluation study endpoint . Implanted pacemaker , defibrillator metallic object inside body limit perform MRI scan . History intolerable adverse event statin therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>multiple sclerosis</keyword>
	<keyword>relapsing-remitting</keyword>
	<keyword>secondary progressive</keyword>
</DOC>